Thank you for your interest in the University of Michigan Division of Infectious Diseases. Since our beginning in 1967, we have steadily grown in size and depth and have become more internally specialized in response to growing needs. This started with the infection control program, and has more recently evolved into distinct specialized programs in HIV/AIDS, transplant infections, and antimicrobial stewardship.
Our research activities have expanded in parallel and our accomplishments have been notable. In the 1970's, we assisted in the discovery of Clostridium difficile colitis. In the 1980's, we were at the forefront of defining how older adults responded to infection and how the clinical aspects of a variety of infections differed with the process of aging. In 2012, our division helped to standardize the treatment of fungal meningitis complicating spinal injections of a steroid preparation that was contaminated during the compounding process by the manufacturer. Today, our research is expansive - ranging from investigating basic mechanisms of viral evolution, the factors that allow HIV to replicate while evading the immune system, the interactions of microbes with their host and the influence of the intestinal microbiome on this interaction, and the identification of risk factors and examination of the epidemiology of drug resistant bacteria that cause hospital infections.
Our division provides both research-oriented and clinical training, allowing fellows the option to develop themselves as physician-scientists or infectious diseases clinicians. More than 80 infectious disease specialists have completed our program since its inception. Our trainees continue to distinguish themselves in patient care, teaching, and research.
I invite you to explore our website and learn more about the exciting work in the clinical, research, and educational realm that we are doing today and discover our distinguished past.
Powel H. Kazanjian, MD, PhD
Chief, Division of Infectious Diseases